🏛️ Verified NIH Record • Updated 2026-03-12
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns (NCT01297400)
🟢 Recruiting Phase2 💊 Investigational Drug / Biologic Sponsor: Skingenix, Inc.
🩺 Plain-English Summary (8th-Grade Level)
To compare MW-III to Silvadene® Cream 1% (Silver Sulfadiazine) with respect to "time to healing" (≥95% re-epithelialization) of a partial thickness target thermal burn.
Who can join: Review the eligibility criteria below.
Location: Valleywise Health Medical Center — Phoenix, Arizona
Age range: 18 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (6 Sites)
- Valleywise Health Medical Center — Phoenix, Arizona
- University of CA Davis Medical Center — Sacramento, California
- MedStar Washington Hospital Center — Washington D.C., District of Columbia
- University of Iowa Health Care — Iowa City, Iowa
- Proactive CR Mexico SA de CV — Irapuato,
- SMIQ S de R. L de CV — Querétaro City,
📞 Contact the Study Coordinator
Phone: (909) 587-1650
Email: vickic@skingenixusa.com
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Burns
- Assessment of Safety and Effectiveness of NovoSorb® BTM in Severe Burns — Phoenix, Arizona
- Topical Methylene Blue-Photodynamic Therapy (MB-PDT) for Burn Wound Infection — Oklahoma City, Oklahoma
- The Effects of Metformin on Morbidity and Mortality in Elderly Patients — Hamilton, Ontario
- A Phase I, Single-blind, Randomized Study of the Safety and Efficacy of Cellularized Integra® Using Autologous Burn-derived Stem Cells — Hamilton, Ontario
- A Pilot Trial of Disposable Nitrous Oxide Canisters in Providing Pain Control During Burn Dressing Changes — Winnipeg, Manitoba
- 4-Aminopyridine to Treat Skin Burns — Tucson, Arizona
Explore by condition: All Burns clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.